| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Nov 5, 2025 | PLUS THERAPEUTICS, INC. | CFO | Buy | 91.3 | +20,000 | 41.55% | ✗ | $10.2K |
| Sep 10, 2024 | Sep 11, 2024 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +4,098 | 71.68% | ✗ | $5.2K |
| May 8, 2024 | May 10, 2024 | PLUS THERAPEUTICS, INC. | CFO | Buy | 91.3 | +4,902 | 601.47% | ✗ | $10K |
| Apr 26, 2022 | Apr 27, 2022 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +3,000 | 32.50% | ✗ | $2K |
| Mar 1, 2022 | Mar 3, 2022 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +2,000 | 27.66% | ✗ | $2.2K |
| Nov 2, 2021 | Nov 4, 2021 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +1,000 | 16.05% | ✗ | $1.9K |
| Oct 26, 2021 | Oct 27, 2021 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +2,000 | 47.28% | ✗ | $3.3K |
| Jul 27, 2021 | Jul 29, 2021 | PLUS THERAPEUTICS, INC. | CFO | Buy | 90.0 | +4,230 | 100.00% | ✗ | $8.4K |